介入性腫瘤器材市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、手術、癌症類型、地區和競爭格局分類，2020-2030年預測

2024年全球介入性腫瘤器材市場規模為27.4億美元，預計2030年將以7.90%的複合年成長率成長至43.2億美元。介入性腫瘤器械是指用於影像引導下微創手術的專用醫療器械，用於診斷、治療和緩解各種癌症。該市場的成長主要受全球癌症發病率上升以及人們對微創治療手段日益成長的需求所驅動，微創治療具有恢復時間短、併發症少等優勢。

主要市場促進因素

主要市場挑戰

這種稀缺性限制了患者獲得先進治療介入的機會，並限制了市場的成長潛力。

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球介入性腫瘤器材市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品分類（栓塞裝置、消融裝置、支撐裝置）
  • 依手術方式分類（熱消融術、非熱消融術、經導管動脈化療栓塞術 (TACE)、經導管動脈放射性栓塞術 (TARE)、經導管動脈栓塞術 (TAE)）
  • 依癌症類型（肝癌、腎癌、肺癌、骨癌、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美介入性腫瘤器材市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲介入性腫瘤器材市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區介入腫瘤器材市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲介入性腫瘤器材市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲介入腫瘤器械市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球介入性腫瘤器材市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Medtronic PLC
• Terumo Corporation
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• HealthTronics, Inc.
• Johnson & Johnson
• Teleflex Inc.
• Angiodynamics Inc.
• MedWaves, Inc.
• Becton, Dickinson, and Company

第16章：策略建議

第17章調查會社について,免責事項

The Global Interventional Oncology Devices Market, valued at USD 2.74 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 4.32 Billion by 2030. Interventional oncology devices represent specialized medical instrumentation employed in image-guided, minimally invasive procedures for the diagnosis, treatment, and palliation of various cancers. The market's expansion is fundamentally driven by the increasing global prevalence of cancer and a growing preference for less invasive therapeutic interventions, which offer advantages such as reduced recovery times and fewer complications.

Key Market Drivers

The increasing global cancer incidence is a significant catalyst for the interventional oncology devices market, generating an expanding patient demographic in need of advanced diagnostic and treatment modalities. The rising number of new cancer diagnoses globally creates a fundamental demand for minimally invasive, image-guided interventions that offer targeted therapy with reduced systemic impact. For example, according to the "Global Cancer Statistics, 2024" report published by the American Cancer Society and the International Agency for Research on Cancer on April 4, 2024, lung cancer was the most frequently diagnosed cancer in 2022, accounting for 2.5 million new cases worldwide, underscoring the substantial and ongoing demand for specialized oncology solutions. This growing burden necessitates a wider array of effective and less invasive tools, directly stimulating the development and adoption of interventional oncology devices.

Key Market Challenges

A notable challenge impeding market expansion is the limited availability of adequately trained interventional oncologists. These specialized medical procedures necessitate a high degree of expertise in image-guided, minimally invasive techniques, making the presence of skilled professionals critical for the adoption and utilization of associated devices. A deficiency in this expert workforce directly restricts the number of procedures that can be performed, thereby hampering the overall demand for interventional oncology instruments.

This scarcity limits patient access to advanced therapeutic interventions and constrains the market's growth potential.

Key Market Trends

Artificial Intelligence and Machine Learning Integration for Precision marks a significant trend in the Global Interventional Oncology Devices Market by refining diagnostic accuracy and therapeutic targeting. The application of sophisticated algorithms allows for the analysis of complex patient data, including genomics and imaging, to guide more precise interventions. According to a EuroAIM/EuSoMII 2024 survey, nearly 48% of European Society of Radiology members are currently using AI systems in their clinical practice, indicating a notable adoption rate within a directly relevant medical specialty. This integration facilitates optimized treatment pathways and improved patient stratification.

Key Market Players

• Medtronic PLC
• Terumo Corporation
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• HealthTronics, Inc.
• Johnson & Johnson
• Teleflex Inc.
• Angiodynamics Inc.
• MedWaves, Inc.
• Becton, Dickinson, and Company

Report Scope:

In this report, the Global Interventional Oncology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Interventional Oncology Devices Market, By Product:

• Embolization Devices
• Ablation Devices
• Support Devices

Interventional Oncology Devices Market, By Procedure:

• Thermal Tumor Ablation
• Non-thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization (TACE)
• Transcatheter Arterial Radioembolization (TARE)
• Transcatheter Arterial Embolization (TAE)

Interventional Oncology Devices Market, By Cancer Type:

• Liver
• Kidney
• Lung
• Bone
• Others

Interventional Oncology Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Interventional Oncology Devices Market.

Available Customizations:

Global Interventional Oncology Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Interventional Oncology Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Embolization Devices, Ablation Devices, Support Devices)
  • 5.2.2. By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE))
  • 5.2.3. By Cancer Type (Liver, Kidney, Lung, Bone, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Interventional Oncology Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Procedure
  • 6.2.3. By Cancer Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Interventional Oncology Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Procedure
      • 6.3.1.2.3. By Cancer Type
  • 6.3.2. Canada Interventional Oncology Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Procedure
      • 6.3.2.2.3. By Cancer Type
  • 6.3.3. Mexico Interventional Oncology Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Procedure
      • 6.3.3.2.3. By Cancer Type

7. Europe Interventional Oncology Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Procedure
  • 7.2.3. By Cancer Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Interventional Oncology Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Procedure
      • 7.3.1.2.3. By Cancer Type
  • 7.3.2. France Interventional Oncology Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Procedure
      • 7.3.2.2.3. By Cancer Type
  • 7.3.3. United Kingdom Interventional Oncology Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Procedure
      • 7.3.3.2.3. By Cancer Type
  • 7.3.4. Italy Interventional Oncology Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Procedure
      • 7.3.4.2.3. By Cancer Type
  • 7.3.5. Spain Interventional Oncology Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Procedure
      • 7.3.5.2.3. By Cancer Type

8. Asia Pacific Interventional Oncology Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Procedure
  • 8.2.3. By Cancer Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Interventional Oncology Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Procedure
      • 8.3.1.2.3. By Cancer Type
  • 8.3.2. India Interventional Oncology Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Procedure
      • 8.3.2.2.3. By Cancer Type
  • 8.3.3. Japan Interventional Oncology Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Procedure
      • 8.3.3.2.3. By Cancer Type
  • 8.3.4. South Korea Interventional Oncology Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Procedure
      • 8.3.4.2.3. By Cancer Type
  • 8.3.5. Australia Interventional Oncology Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Procedure
      • 8.3.5.2.3. By Cancer Type

9. Middle East & Africa Interventional Oncology Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Procedure
  • 9.2.3. By Cancer Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Interventional Oncology Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Procedure
      • 9.3.1.2.3. By Cancer Type
  • 9.3.2. UAE Interventional Oncology Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Procedure
      • 9.3.2.2.3. By Cancer Type
  • 9.3.3. South Africa Interventional Oncology Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Procedure
      • 9.3.3.2.3. By Cancer Type

10. South America Interventional Oncology Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Procedure
  • 10.2.3. By Cancer Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Interventional Oncology Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Procedure
      • 10.3.1.2.3. By Cancer Type
  • 10.3.2. Colombia Interventional Oncology Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Procedure
      • 10.3.2.2.3. By Cancer Type
  • 10.3.3. Argentina Interventional Oncology Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Procedure
      • 10.3.3.2.3. By Cancer Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Interventional Oncology Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Terumo Corporation
• 15.3. Boston Scientific Corporation
• 15.4. Merit Medical Systems, Inc.
• 15.5. HealthTronics, Inc.
• 15.6. Johnson & Johnson
• 15.7. Teleflex Inc.
• 15.8. Angiodynamics Inc.
• 15.9. MedWaves, Inc.
• 15.10. Becton, Dickinson, and Company

16. Strategic Recommendations

17. About Us & Disclaimer